Skip to main content
Top
Published in: Diagnostic Pathology 1/2014

Open Access 01-12-2014 | Research

Insulin and risk of diabetic retinopathy in patients with type 2 diabetes mellitus: data from a meta-analysis of seven cohort studies

Authors: Chun Zhao, Weifang Wang, Ding Xu, Hui Li, Min Li, Fang Wang

Published in: Diagnostic Pathology | Issue 1/2014

Login to get access

Abstract

Background

Type 2 diabetes mellitus (T2DM) is a chronic incurable disease associated with multi-systemic complications. The chronic complications related to T2DM induce growing burden to the national health system. Diabetic retinopathy (DR) is the most serious ocular complication associated with T2DM and one of the leading causes of secondary blindness. The association between insulin use and DR risk has also been reported in different studies.

Methods

In order to obtain more informative results on the relationship between insulin intake and risk of DR and to take into account more recent evidence, we conducted this meta-analysis by including all available relevant cohort studies. A systemic literature search was performed via electronic databases inclu-apding Pubmed and EMBASE to identify all available relevant studies until February 2014. A total of seven cohort studies were included in this meta-analysis. In this meta-analysis, we conducted a rigorous search of all available published cohort studies to quantify the possible association between insulin use and incidental DR in individuals with type 2 diabetes.

Results

Although major heterogeneity existed in this study, the significant association between insulin use and risk of DR was detected. The subgroup analyses by study design, region, data source and adjustment of HbA1c generated similar results. Also, when the DM duration was adjusted, no result was reported with significant difference.

Conclusion

The results of this meta-analysis helps to better explore the role of insulin use in DR risk development. Meanwhile, our results are statistically robust and yield important conclusions. The underlying mechanism by which insulin use increases DR risk should be explored in future in vitro and in vivo studies. Additional large-scale, well-designed studies with sufficient data are needed to confirm our findings.

Virtual Slides

Literature
1.
go back to reference Poanta L, Porojan M, Dumitrascu DL: Heart rate variability and diastolic dysfunction in patients with type 2 diabetes mellitus. Acta Diabetol. 2011, 48: 191-196.PubMedCrossRef Poanta L, Porojan M, Dumitrascu DL: Heart rate variability and diastolic dysfunction in patients with type 2 diabetes mellitus. Acta Diabetol. 2011, 48: 191-196.PubMedCrossRef
2.
go back to reference Alimohammadi S, Hobbenaghi R, Javanbakht J, Kheradmand D, Mortezaee R, Tavakoli M, Khadivar F, Akbari H: Protective and antidiabetic effects of extract from Nigella sativa on blood glucose concentrations against streptozotocin (STZ)-induced diabetic in rats: an experimental study with histopathological evaluation. Diagn Pathol. 2013, 8: 137-PubMedPubMedCentralCrossRef Alimohammadi S, Hobbenaghi R, Javanbakht J, Kheradmand D, Mortezaee R, Tavakoli M, Khadivar F, Akbari H: Protective and antidiabetic effects of extract from Nigella sativa on blood glucose concentrations against streptozotocin (STZ)-induced diabetic in rats: an experimental study with histopathological evaluation. Diagn Pathol. 2013, 8: 137-PubMedPubMedCentralCrossRef
3.
go back to reference Liu L, Jiao J, Wang Y, Wu J, Huang D, Teng W, Chen L: TGF-beta1 gene polymorphism in association with diabetic retinopathy susceptibility: a systematic review and meta-analysis. PLoS One. 2014, 9: e94160-PubMedPubMedCentralCrossRef Liu L, Jiao J, Wang Y, Wu J, Huang D, Teng W, Chen L: TGF-beta1 gene polymorphism in association with diabetic retinopathy susceptibility: a systematic review and meta-analysis. PLoS One. 2014, 9: e94160-PubMedPubMedCentralCrossRef
5.
go back to reference Salti HI, Nasrallah MP, Taleb NM, Merheb M, Haddad S, El-Annan J, Khouri A, Salti IS: Prevalence and determinants of retinopathy in a cohort of Lebanese type II diabetic patients. Can J Ophthalmol. 2009, 44: 308-313.PubMedCrossRef Salti HI, Nasrallah MP, Taleb NM, Merheb M, Haddad S, El-Annan J, Khouri A, Salti IS: Prevalence and determinants of retinopathy in a cohort of Lebanese type II diabetic patients. Can J Ophthalmol. 2009, 44: 308-313.PubMedCrossRef
6.
go back to reference Rema M, Premkumar S, Anitha B, Deepa R, Pradeepa R, Mohan V: Prevalence of diabetic retinopathy in urban India: the Chennai Urban Rural Epidemiology Study (CURES) eye study, I. Invest Ophthalmol Vis Sci. 2005, 46: 2328-2333.PubMedCrossRef Rema M, Premkumar S, Anitha B, Deepa R, Pradeepa R, Mohan V: Prevalence of diabetic retinopathy in urban India: the Chennai Urban Rural Epidemiology Study (CURES) eye study, I. Invest Ophthalmol Vis Sci. 2005, 46: 2328-2333.PubMedCrossRef
7.
go back to reference Campbell PT, Deka A, Jacobs EJ, Newton CC, Hildebrand JS, McCullough ML, Limburg PJ, Gapstur SM: Prospective study reveals associations between colorectal cancer and type 2 diabetes mellitus or insulin use in men. Gastroenterology. 2010, 139: 1138-1146.PubMedCrossRef Campbell PT, Deka A, Jacobs EJ, Newton CC, Hildebrand JS, McCullough ML, Limburg PJ, Gapstur SM: Prospective study reveals associations between colorectal cancer and type 2 diabetes mellitus or insulin use in men. Gastroenterology. 2010, 139: 1138-1146.PubMedCrossRef
8.
go back to reference Jongsareejit A, Potisat S, Krairittichai U, Sattaputh C, Arunratanachote W: The Thai DMS Diabetes Complications (DD.Comp.) project: prevalence and risk factors of diabetic retinopathy in Thai patients with type 2 diabetes mellitus. J Med Assoc Thai. 2013, 96: 1476-1482.PubMed Jongsareejit A, Potisat S, Krairittichai U, Sattaputh C, Arunratanachote W: The Thai DMS Diabetes Complications (DD.Comp.) project: prevalence and risk factors of diabetic retinopathy in Thai patients with type 2 diabetes mellitus. J Med Assoc Thai. 2013, 96: 1476-1482.PubMed
9.
go back to reference Moher D, Liberati A, Tetzlaff J, Altman DG: Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009, 339: b2535-PubMedPubMedCentralCrossRef Moher D, Liberati A, Tetzlaff J, Altman DG: Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009, 339: b2535-PubMedPubMedCentralCrossRef
10.
go back to reference Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB: Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000, 283: 2008-2012.PubMedCrossRef Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB: Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000, 283: 2008-2012.PubMedCrossRef
11.
go back to reference Colmers IN, Bowker SL, Tjosvold LA, Johnson JA: Insulin use and cancer risk in patients with type 2 diabetes: a systematic review and meta-analysis of observational studies. Diabetes Metab. 2012, 38: 485-506.PubMedCrossRef Colmers IN, Bowker SL, Tjosvold LA, Johnson JA: Insulin use and cancer risk in patients with type 2 diabetes: a systematic review and meta-analysis of observational studies. Diabetes Metab. 2012, 38: 485-506.PubMedCrossRef
12.
go back to reference Gunnlaugsdottir E, Halldorsdottir S, Klein R, Eiriksdottir G, Klein BE, Benediktsson R, Harris TB, Launer LJ, Aspelund T, Gudnason V, Cotch MF, Jonasson F: Retinopathy in old persons with and without diabetes mellitus: the Age, Gene/Environment Susceptibility–Reykjavik Study (AGES-R). Diabetologia. 2012, 55: 671-680.PubMedPubMedCentralCrossRef Gunnlaugsdottir E, Halldorsdottir S, Klein R, Eiriksdottir G, Klein BE, Benediktsson R, Harris TB, Launer LJ, Aspelund T, Gudnason V, Cotch MF, Jonasson F: Retinopathy in old persons with and without diabetes mellitus: the Age, Gene/Environment Susceptibility–Reykjavik Study (AGES-R). Diabetologia. 2012, 55: 671-680.PubMedPubMedCentralCrossRef
13.
go back to reference Bertelsen G, Peto T, Lindekleiv H, Schirmer H, Solbu MD, Toft I, Sjolie AK, Njolstad I: Tromso eye study: prevalence and risk factors of diabetic retinopathy. Acta Ophthalmol. 2013, 91: 716-721.PubMedCrossRef Bertelsen G, Peto T, Lindekleiv H, Schirmer H, Solbu MD, Toft I, Sjolie AK, Njolstad I: Tromso eye study: prevalence and risk factors of diabetic retinopathy. Acta Ophthalmol. 2013, 91: 716-721.PubMedCrossRef
14.
go back to reference Schweitzer K, Ehmann D, Garcia R, Alport E: Oculoleptomeningeal amyloidosis in 3 individuals with the transthyretin variant Tyr69His. Can J Ophthalmol. 2009, 44: 317-319.PubMedCrossRef Schweitzer K, Ehmann D, Garcia R, Alport E: Oculoleptomeningeal amyloidosis in 3 individuals with the transthyretin variant Tyr69His. Can J Ophthalmol. 2009, 44: 317-319.PubMedCrossRef
15.
go back to reference Romero-Aroca P, Fernandez-Alart J, Baget-Bernaldiz M, Mendez-Marin I, Salvat-Serra M: Diabetic retinopathy epidemiology in type II diabetic patients: effect of the changes in the diagnostic criteria and stricter control of the diabetes between 1993 and 2005 on the incidence of diabetic retinopathy. Arch Soc Esp Oftalmol. 2007, 82: 209-218.PubMedCrossRef Romero-Aroca P, Fernandez-Alart J, Baget-Bernaldiz M, Mendez-Marin I, Salvat-Serra M: Diabetic retinopathy epidemiology in type II diabetic patients: effect of the changes in the diagnostic criteria and stricter control of the diabetes between 1993 and 2005 on the incidence of diabetic retinopathy. Arch Soc Esp Oftalmol. 2007, 82: 209-218.PubMedCrossRef
16.
go back to reference Hove MN, Kristensen JK, Lauritzen T, Bek T: The prevalence of retinopathy in an unselected population of type 2 diabetes patients from Arhus County, Denmark. Acta Ophthalmol Scand. 2004, 82: 443-448.PubMedCrossRef Hove MN, Kristensen JK, Lauritzen T, Bek T: The prevalence of retinopathy in an unselected population of type 2 diabetes patients from Arhus County, Denmark. Acta Ophthalmol Scand. 2004, 82: 443-448.PubMedCrossRef
17.
go back to reference Henricsson M, Nilsson A, Janzon L, Groop L: The effect of glycaemic control and the introduction of insulin therapy on retinopathy in non-insulin-dependent diabetes mellitus. Diabet Med. 1997, 14: 123-131.PubMedCrossRef Henricsson M, Nilsson A, Janzon L, Groop L: The effect of glycaemic control and the introduction of insulin therapy on retinopathy in non-insulin-dependent diabetes mellitus. Diabet Med. 1997, 14: 123-131.PubMedCrossRef
18.
go back to reference Deng Y, Yang XF, Gu H, Lim A, Ulziibat M, Snellingen T, Xu J, Ma K, Liu NP: Association of C(-106)T polymorphism in aldose reductase gene with diabetic retinopathy in Chinese patients with type 2 diabetes mellitus. Chin Med Sci J. 2014, 29: 1-6.PubMedCrossRef Deng Y, Yang XF, Gu H, Lim A, Ulziibat M, Snellingen T, Xu J, Ma K, Liu NP: Association of C(-106)T polymorphism in aldose reductase gene with diabetic retinopathy in Chinese patients with type 2 diabetes mellitus. Chin Med Sci J. 2014, 29: 1-6.PubMedCrossRef
19.
go back to reference Silpa-Archa S, Sukhawarn R: Prevalence and associated factors of diabetic retinopathy in Chandrubeksa Hospital, Directorate of Medical Services, Royal Thai Air Force. J Med Assoc Thai. 2012, 95 (Suppl 4): S43-S49.PubMed Silpa-Archa S, Sukhawarn R: Prevalence and associated factors of diabetic retinopathy in Chandrubeksa Hospital, Directorate of Medical Services, Royal Thai Air Force. J Med Assoc Thai. 2012, 95 (Suppl 4): S43-S49.PubMed
20.
go back to reference Zhang T, Pang C, Li N, Zhou E, Zhao K: Plasminogen activator inhibitor-1 4G/5G polymorphism and retinopathy risk in type 2 diabetes: a meta-analysis. BMC Med. 2013, 11: 1-PubMedPubMedCentralCrossRef Zhang T, Pang C, Li N, Zhou E, Zhao K: Plasminogen activator inhibitor-1 4G/5G polymorphism and retinopathy risk in type 2 diabetes: a meta-analysis. BMC Med. 2013, 11: 1-PubMedPubMedCentralCrossRef
21.
go back to reference Yin S, Bai H, Jing D: Insulin therapy and colorectal cancer risk among type 2 diabetes mellitus patients: a systemic review and meta-analysis. Diagn Pathol. 2014, 9: 91-PubMedPubMedCentralCrossRef Yin S, Bai H, Jing D: Insulin therapy and colorectal cancer risk among type 2 diabetes mellitus patients: a systemic review and meta-analysis. Diagn Pathol. 2014, 9: 91-PubMedPubMedCentralCrossRef
22.
go back to reference Wang L, Cai S, Teng Z, Zhao X, Chen X, Bai X: Insulin therapy contributes to the increased risk of colorectal cancer in diabetes patients: a meta-analysis. Diagn Pathol. 2013, 8: 180-PubMedPubMedCentralCrossRef Wang L, Cai S, Teng Z, Zhao X, Chen X, Bai X: Insulin therapy contributes to the increased risk of colorectal cancer in diabetes patients: a meta-analysis. Diagn Pathol. 2013, 8: 180-PubMedPubMedCentralCrossRef
Metadata
Title
Insulin and risk of diabetic retinopathy in patients with type 2 diabetes mellitus: data from a meta-analysis of seven cohort studies
Authors
Chun Zhao
Weifang Wang
Ding Xu
Hui Li
Min Li
Fang Wang
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Diagnostic Pathology / Issue 1/2014
Electronic ISSN: 1746-1596
DOI
https://doi.org/10.1186/1746-1596-9-130

Other articles of this Issue 1/2014

Diagnostic Pathology 1/2014 Go to the issue